Malignant neoplasm of cardia
ICD-10 C16.0 is a billable code used to indicate a diagnosis of malignant neoplasm of cardia.
C16.0 refers to malignant neoplasms located at the cardia, which is the region where the esophagus meets the stomach. This type of gastric cancer is often associated with chronic infection by Helicobacter pylori (H. pylori), a bacterium that can lead to gastric inflammation and is a known risk factor for gastric malignancies. The clinical presentation may include symptoms such as dysphagia, weight loss, and abdominal pain. Diagnosis typically involves endoscopy and biopsy, with histological examination confirming malignancy. Staging of gastric cancer is crucial for treatment planning and is based on the TNM classification system, which assesses tumor size (T), lymph node involvement (N), and the presence of metastasis (M). Treatment options may include surgical resection, such as gastrectomy, chemotherapy, and radiation therapy, depending on the stage of the disease. Accurate coding is essential for appropriate reimbursement and tracking of cancer treatment outcomes.
Detailed pathology reports, staging information, and treatment plans.
Patients presenting with symptoms of gastric cancer, undergoing chemotherapy or surgical interventions.
Ensure accurate staging and documentation of treatment response.
Endoscopy reports, biopsy results, and H. pylori testing.
Patients with dyspepsia or gastrointestinal bleeding undergoing diagnostic procedures.
Document any findings related to H. pylori and its treatment.
Used for patients with malignant neoplasm of the cardia requiring surgical intervention.
Operative reports detailing the procedure and findings.
Oncology and surgery documentation must align for accurate coding.
H. pylori infection is a major risk factor for gastric cancer, leading to chronic inflammation and increasing the likelihood of malignant transformation.
